CSU

Clinical trials for CSU explained in plain language.

Never miss a new study

Get alerted when new CSU trials appear

Sign up with your email to follow new studies for CSU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Could a JAK inhibitor tame chronic hives? new trial aims to find out

Disease control Terminated

This study tested whether the drug ritlecitinib can safely control chronic spontaneous urticaria (CSU) — hives and itching lasting over six weeks. The trial planned to enroll adults aged 18–65 who would take the drug daily for 12 weeks and track their symptoms. However, the study…

Matched conditions: CSU

Phase: PHASE2 • Sponsor: Ahuva D Cices • Aim: Disease control

Last updated Apr 24, 2026 16:20 UTC

CSU

Get alerted when new CSU trials appear

Could a JAK inhibitor tame chronic hives? new trial aims to find out